Fosun Pharma Releases 2025 ESG and Sustainability Report

Bulletin Express
04/21

On 21 April 2026, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”) announced that its 2025 Environmental, Social and Governance (ESG) and Sustainability Report is now available in both English and Chinese on the company’s website (www.fosunpharma.com) and on HKEX’s disclosure platform (www.hkexnews.hk).

Shareholders unable to access the online document may obtain a complimentary printed copy by submitting a signed written request to the H-share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.

Further enquiries can be directed to the registrar’s hotline at +852 2980 1333, Monday to Friday, 9:00 a.m. to 6:00 p.m., excluding public holidays.

The notice was issued under the authority of Chairman Chen Yuqing.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10